Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms

Phase: PHASE2 | Sponsor: Brugmann University Hospital | Compound: Psilocybin

Status

recruiting

Institution

Brugmann University Hospital

Start date

2024-02-15

End date

2026-06-15

Registry ID

NCT06160232

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.